financetom
Business
financetom
/
Business
/
Stantec Q3 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stantec Q3 Adjusted Earnings, Revenue Rise
Nov 13, 2025 2:52 PM

05:44 PM EST, 11/13/2025 (MT Newswires) -- Stantec ( STN ) reported Q3 adjusted earnings late Thursday of CA$1.53 ($1.09) per diluted share, up from CA$1.30 a year ago.

Analysts surveyed by FactSet expected CA$1.53.

Net revenue for the three months ended Sept. 30 rose to CA$1.71 billion from CA$1.53 billion a year earlier.

Analysts polled by FactSet expected CA$1.71 billion.

For 2025, the company kept its adjusted EPS growth guidance of 18.5% to 21.5% on net revenue growth of 10% to 12%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Klaviyo Q1 Tops Consensus, Issues Guidance; Shares Rise After-Hours
Klaviyo Q1 Tops Consensus, Issues Guidance; Shares Rise After-Hours
May 8, 2024
05:37 PM EDT, 05/08/2024 (MT Newswires) -- Klaviyo ( KVYO ) late Wednesday reported Q1 adjusted net income of $0.13 per diluted share, compared with $0.10 a year ago. Analysts polled by Capital IQ expected $0.11. Revenue for the quarter ended March 31 was $210 million, up from $156.1 million a year earlier. Analysts expected $202.1 million. For Q2, the...
Jpmorgan Chase Insider Sold Shares Worth $984,876, According to a Recent SEC Filing
Jpmorgan Chase Insider Sold Shares Worth $984,876, According to a Recent SEC Filing
May 8, 2024
05:33 PM EDT, 05/08/2024 (MT Newswires) -- Ashley Bacon, Chief Risk Officer, on May 08, 2024, sold 5,086 shares in Jpmorgan Chase ( JPM ) for $984,876. Following the Form 4 filing with the SEC, Bacon has control over a total of 217,351 shares of the company, with 217,351 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/19617/000122520824005809/xslF345X03/doc4.xml Price: 195.55, Change: -0.10, Percent...
Equinix Q1 Adjusted Funds From Operations, Revenue Rise; Full-Year Guidance Lowered
Equinix Q1 Adjusted Funds From Operations, Revenue Rise; Full-Year Guidance Lowered
May 8, 2024
05:35 PM EDT, 05/08/2024 (MT Newswires) -- Equinix ( EQIX ) reported Q1 adjusted funds from operations late Wednesday of $8.86 per diluted share, up from $8.59 a year earlier. Analysts surveyed by Capital IQ expected $8.59. Revenue for the quarter ended March 31 was $2.13 billion, up from nearly $2 billion a year earlier. Analysts surveyed by Capital IQ...
Revolution Medicines Q1 Net Loss Narrows
Revolution Medicines Q1 Net Loss Narrows
May 8, 2024
05:37 PM EDT, 05/08/2024 (MT Newswires) -- Revolution Medicines ( RVMD ) reported a Q1 net loss Wednesday of $0.70 per share, narrowing from a loss of $0.72 a year earlier. Analysts polled by Capital IQ expected a loss of $0.75. The company did not record any revenue for the quarter ended March 31, compared with $7 million a year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved